Organizers claimed that nearly 2 million Hong Kong protesters took to the streets Sunday in a rally to demand the city's top official resign a day after she suspended — but...China Politicsread more
Heavy rains caused unprecedented delays in planting this year and contributed to record floods across the central United States.Agricultureread more
Stocks in Asia traded mixed on Monday as investors await a U.S. Federal Reserve meeting set to happen later in the week stateside.Asia Marketsread more
Although Cook did not mention companies by name, his commencement speech in Silicon Valley's backyard mentioned data breaches, privacy violations, and even made reference to...Technologyread more
In the survey, 66% of Democratic primary voters say they'd be enthusiastic or comfortable about Biden as their nominee to take on President Trump in the 2020 election. Just...Politicsread more
U.S. ambassador to Israel David Friedman called the gesture a "birthday present" to Trump, who turned 73 on Friday.Politicsread more
The outlook for Germany's economy and political stability are more uncertain than ever, writes Michael Ivanovitch.World Economyread more
Hong Kong democracy activist Joshua Wong walked free from prison on Monday after serving nearly five weeks for contempt of court, pledging to join a mass protest movement...China Politicsread more
The agreement, which is on the framework for the plan of adjustment, provide for more than a 60% average haircut for all $35 billion, a 36% haircut on pre-2012 general...Bondsread more
Target's registers were down on Saturday for several hours preventing customers from checking out.Retailread more
The newspaper wrote that Goldman's executive are hoping CEO David Solomon's changes to a firm that historically thrived in investment banking and trading will boost its...US Marketsread more
May 28 (Reuters) - Johnson & Johnson is set to face trial on Tuesday in a multi-billion dollar lawsuit by the state of Oklahoma accusing the drugmaker of helping fuel the opioid epidemic.
The case, filed by Oklahoma Attorney General Mike Hunter, is the first of more than 2,000 lawsuits to go to trial over claims that opioid manufacturers deceptively marketed painkillers to downplay the risk of addiction.
Opioids, including prescription painkillers and heroin, played a role in a record 47,600 U.S. overdose deaths in 2017, according to the U.S. Centers for Disease Control and Prevention.
The company denies wrongdoing and says it marketed its products appropriately. The nonjury trial will be heard by Cleveland County District Judge Thad Balkman in Norman, Oklahoma.
The following is a summary of where and how the opioid litigation is playing out across the United States:
* The lawsuits allege drug manufacturers like Purdue, Johnson & Johnson, Teva and Endo International Plc carried out marketing campaigns that deceptively promoted the benefits of using opioids to treat chronic, rather than short-term. Many of them also name as defendants wholesale drug distributors like AmerisourceBergen, McKesson Corp and Cardinal Health who are accused of ignoring red flags indicating the painkillers were being diverted for improper uses. The suits generally seek to recover money that states and municipalities say they have spent and will incur to address drug abuses and overdoses.
* Of the more than 2,000 lawsuits nationally, the majority of cases - 1,850 brought primarily by municipalities and counties - are consolidated before a federal judge in Cleveland, Ohio.
* U.S. District Judge Dan Polster, who oversees the federal litigation, has pushed for a global settlement, saying at a hearing in January 2018 that he wanted to "do something meaningful to abate this crisis." But such a settlement has not been reached, prompting the judge to begin scheduling trials. The first federal trial begins in October.
* Many other lawsuits are pending in state courts, particularly ones brought by state attorneys general like Hunter. The vast majority of these suits are against Purdue, which launched OxyContin in 1996. Many also name members of the wealthy Sackler family, which owns Purdue.
* Hunter's lawsuit against J&J alleges its marketing of opioids created a public nuisance that helped cause the epidemic and that the company should be required to pay for correcting, or "abating," that problem. The state has said in court filings the potential cost could reach $17.5 billion.
* The drugmakers deny wrongdoing, arguing their products carried U.S. Food and Drug Administration-approved labels that warned of the addictive risks of opioids. They say they did not cause the damage the epidemic has had on states and localities.
* Purdue, which has been considering filing for bankruptcy amid the litigation, agreed in March along with the Sacklers to a $270 million settlement with Oklahoma. The Sacklers were not named as defendants in that case and voluntarily agreed to contribute to the settlement.
* Teva on the eve of trial agreed on Sunday to pay $85 million to resolve Oklahoma's claims against the company.
(Reporting by Nate Raymond in Boston; Editing by Noeleen Walder and Paul Simao)